Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Hematopoietic and Lymphoid Cell Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm

Cancer Family

Hematopoietic and Lymphoid Cell Neoplasm

CI-CAN-00000023Explore in graph →

HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items

NCIt: C27134
DOID: 2531
MeSH: D019337

Overview
Statistics
Survival
Genomics60
Variants & evidence1009
Drugs99
Trials18680
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (735)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 576–600 of 735 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Acute promyelocytic leukemia with PML/RARA (bcr1, bcr2 and bcr3) transcripts in a pediatric patient.
· Oncol Lett · 2024 · PMID 38304177 · validated civic_curation pubmed
Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia.
· Acta Haematol · 2007 · PMID 17934255 · validated civic_curation pubmed
Identification and monitoring of atypical PML/RARA fusion transcripts in acute promyelocytic leukemia.
· Genes Chromosomes Cancer · 2019 · PMID 30421475 · validated civic_curation pubmed
Concurrent EPOR::IGH fusion gene and numerous cytoplasmic granules in BCR::ABL1-like B-lymphoblastic leukemia.
· Pediatr Blood Cancer · 2024 · PMID 38302862 · validated civic_curation pubmed
From the archives of MD Anderson Cancer Center: BCR-ABL1-like B acute lymphoblastic leukemia with IGH/EPOR fusion.
· Ann Diagn Pathol · 2020 · PMID 32330662 · validated civic_curation pubmed
Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia.
· Haematologica · 2021 · PMID 34196168 · validated civic_curation pubmed
Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia.
· Cancer Gene Ther · 2022 · PMID 35022522 · validated civic_curation

Showing 576–600 of 735 publications

← Previous
1
…
23
24
25
…
30
Next →

Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.

· J Clin Oncol · 2009 · PMID 19636007 · validated civic_curation pubmed

Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature.

· Int J Clin Exp Med · 2015 · PMID 26221234 · validated civic_curation pubmed

Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

· J Clin Oncol · 2013 · PMID 23835704 · validated civic_curation pubmed

Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.

· JAMA · 2011 · PMID 21505136 · validated civic_curation pubmed

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.

· Exp Hematol · 2016 · PMID 27181063 · validated civic_curation pubmed

Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia.

· Clin Cancer Res · 2013 · PMID 23969938 · validated civic_curation pubmed

Vemurafenib response in 2 patients with posttransplant refractory BRAF V600E-mutated multiple myeloma.

· Clin Lymphoma Myeloma Leuk · 2014 · PMID 24997557 · validated civic_curation pubmed

Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.

· Br J Haematol · 2013 · PMID 23480694 · validated civic_curation pubmed

Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.

· Br J Haematol · 2014 · PMID 24456122 · validated civic_curation pubmed

Comprehensive genomic profiling identifies a novel TNKS2-PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy.

· Blood Cancer J · 2015 · PMID 25658984 · validated civic_curation pubmed

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.

· Blood · 2001 · PMID 11675361 · validated civic_curation pubmed

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

· Blood · 2016 · PMID 26712909 · validated civic_curation pubmed

Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.

· Haematologica · 2018 · PMID 29773603 · validated civic_curation pubmed

Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation.

· Leukemia · 2012 · PMID 21818111 · validated civic_curation pubmed

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.

· J Med Genet · 2010 · PMID 20543203 · validated civic_curation pubmed

Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.

· Haematologica · 2016 · PMID 27125982 · validated civic_curation pubmed

Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.

· Oncogene · 2003 · PMID 12944919 · validated civic_curation pubmed

Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.

· Blood Adv · 2020 · PMID 31905241 · validated civic_curation pubmed